Justin J. Leong

发表

Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.

George E. Katibah, T. Gajewski, D. Kanne, 2015, Cell reports.

Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity.

Yan Feng, S. Bender, Thomas E. Hudson, 2018, Cell reports.

STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection.

D. Portnoy, Chris S. Rae, N. Cadieux, 2018, Cell reports.

STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade

D. Pardoll, D. Portnoy, D. Kanne, 2015, Science Translational Medicine.

STING-Activating Adjuvan ts Elicit a Th 17 Immune Response and Protect against Mycobacterium tuberculosis Infection Graphical

D. Portnoy, Chris S. Rae, N. Cadieux, 2018 .

Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity.

Yan Feng, S. Bender, Thomas E. Hudson, 2019, Cell reports.

Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.

George E. Katibah, T. Gajewski, D. Kanne, 2015, Cell reports.

Abstract SY39-02: Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity

John A. Tallarico, Yan Feng, S. Kasibhatla, 2016 .